ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,196 | -32,925 | -21,335 | -10,540 | -47,528 |
| Depreciation Amortization | 168 | 129 | 88 | 45 | 137 |
| Accounts receivable | N/A | N/A | N/A | -68 | N/A |
| Other Working Capital | 2,777 | 4,119 | 3,873 | 2,683 | -1,579 |
| Other Operating Activity | 3,154 | 2,782 | 2,332 | 1,720 | 30,538 |
| Operating Cash Flow | $-40,098 | $-25,895 | $-15,042 | $-6,161 | $-18,431 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 3,026 |
| PPE Investments | -60 | -27 | -24 | -8 | -166 |
| Investing Cash Flow | $-60 | $-27 | $-24 | $-8 | $2,861 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 48,455 | 31,589 | 31,589 | 17,473 | 11,353 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 22,315 |
| Financing Cash Flow | $48,455 | $31,589 | $31,589 | $17,473 | $33,668 |
| Beginning Cash Position | 29,859 | 29,859 | 29,859 | 29,859 | 11,761 |
| End Cash Position | 38,155 | 35,526 | 46,382 | 41,163 | 29,859 |
| Net Cash Flow | $8,297 | $5,668 | $16,524 | $11,305 | $18,098 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,098 | -25,895 | -15,042 | -6,161 | -18,431 |
| Capital Expenditure | -63 | -29 | -24 | -8 | -166 |
| Free Cash Flow | -40,161 | -25,924 | -15,066 | -6,169 | -18,597 |